MedTrace Logo

Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism

NCT00693953 · Status: WITHDRAWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2009-10-02

No results posted yet for this study

Summary

Individuals with Autism Spectrum Disorder will have abnormal DESA® results. Our objective is to use neuroelectrical measures to determine the degree of processing abnormalities in individuals with Autism. The study will survey processing patterns and will locate and evaluate the degree(s) of abnormalities for further study. The abnormal results of comprehensive neuroelectrical evaluations of individuals with Autism when compared to the normative database will provide objective, verifiable, neurophysiological information with which to form novel approaches to the disorder.

Conditions

  • Autistic Disorder
  • Autism, Early Infantile
  • Autism, Infantile
  • Asperger Syndrome

Sponsors & Collaborators

  • Yellen & Associates, Inc.

    lead OTHER

Principal Investigators

  • Andrew G Yellen, PhD · President, Yellen & Associates, Inc.

  • Thomas Schweller, MD · Neurologist

Eligibility

Min Age
5 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-01-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00693953 on ClinicalTrials.gov